$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Dividend Kings Face-Off: Johnson & Johnson (JNJ) Vs. Procter & Gamble (PG)
02:16pm, Friday, 25'th Apr 2025
If you are someone who thinks investments should generate regular income, it is important to watch out for dividend stocks.
The first a approved fully-human, dual-acting interleukin-23 (IL-23) inhibitor in moderately to severely active ulcerative colitis, 1 , 2 , 3 , 4 , 5 guselkumab showed statistically higher rates of en
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:05am, Thursday, 24'th Apr 2025
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
3 Dividend Kings That Have Raised Their Payouts in 2025
08:34am, Thursday, 24'th Apr 2025
If you want to collect a lot of dividend income, it's important to focus on more than just a stock's current yield. Stocks that consistently grow their payouts over the years can be far more valuable
Johnson & Johnson Just Proved The Bears Wrong Again
07:46am, Thursday, 24'th Apr 2025
Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. It beat the consensus estimates again by a wide margin, thanks to its leading positions in the oncology
In the Wake of the Trump Tariff Crash: 2 Unparalleled Dividend Stocks to Buy at a Discount Right Now
03:51am, Thursday, 24'th Apr 2025
Every so often, Wall Street offers a reminder to investors that, despite popular belief, stocks don't rise in a straight line. Although the annualized return of stocks over the last century trumps all
Dividend Kings Down Today: Why Johnson & Johnson (JNJ), Coca-Cola (KO) and Procter & Gamble (PG) Are Sliding
11:06am, Wednesday, 23'rd Apr 2025
Some analysts expect Procter & Gamble to cut its forecast thanks to uncertainty over spending with global trade tensions.
Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-Term
10:46am, Wednesday, 23'rd Apr 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
2025 Dividend Kings: Weathering Tariff Volatility Better Than The Market
09:58am, Wednesday, 23'rd Apr 2025
The Dividend Kings are outperforming the S&P 500 in 2025 by 8.94%. Top performers include National Fuel & Gas (+28.88%), Consolidated Edison (+28.10%), and Middlesex Water Company (+21.00%). Promising
Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom
11:13am, Tuesday, 22'nd Apr 2025
Trump's tariff policy is the latest uncertainty to plague the pharmaceutical sector.
Two Stocks To Consider During Market Unrest To Provide Income Stability
07:30am, Tuesday, 22'nd Apr 2025
Investors should remain calm amid market volatility and consider buying during price dips, with 2025 expected to see more turbulence. Kenvue's strong brand portfolio and solid liquidity offer price st
Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA
09:36am, Monday, 21'st Apr 2025
TAR-200 monotherapy shows highest complete response with sustained benefits in 12-month data from Phase 2b SunRISe-1 study (Cohort 2) Compelling first results from Cohort 4 of Phase 2b SunRISe-1 study
LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed
09:00am, Monday, 21'st Apr 2025
The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.
2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government
07:30am, Sunday, 20'th Apr 2025
In 2011, following the difficulty caused by the Great Recession, S&P Global Ratings (formerly Standard & Poor's) downgraded the long-term credit outlook of the United States from its highest designati
3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now
10:30am, Saturday, 19'th Apr 2025
Dividend stocks can be fantastic investments. The best ones pay an attractive and growing stream of dividend income while also delivering healthy stock price appreciation over the long term.
Sign In
Buy JNJ